| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 05, 2026 |
Merck & Co Inc
MRK
|
BUY |
$146.00
Est. +14%
|
$128.04 | $135.68 |
Pending
|
$135.55
+5.9%
|
| Jul 13, 2026 |
Merck & Co Inc
MRK
|
BUY |
$145.00
Est. +17%
|
$123.54 | $135.68 |
Pending
|
$135.55
+9.7%
|
| Jul 08, 2026 |
Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
|
BUY |
$76.00
Est. +77%
|
$42.96 | $43.69 |
Pending
|
$28.89
-32.8%
|
| Jun 26, 2026 |
Johnson & Johnson
JNJ
|
BUY |
$270.00
Est. +6%
|
$253.56 | $274.90 |
Precision Hit (±3%)
|
$262.08
+3.4%
|
| Jun 25, 2026 |
Travere Therapeutics Inc
TVTX
|
BUY |
$65.00
Est. +9%
|
$59.40 | $66.24 |
Precision Hit (±3%)
|
$61.41
+3.4%
|
| Jun 02, 2026 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$47.00
Est. +153%
|
$18.59 | $24.09 |
Pending
|
$23.81
+28.1%
|
| Jun 02, 2026 |
Merck & Co Inc
MRK
|
BUY |
$140.00
Est. +22%
|
$115.21 | $135.68 |
Pending
|
$135.55
+17.7%
|
| May 08, 2026 |
Insmed Inc
INSM
|
BUY |
$226.00
Est. +115%
|
$105.00 | $137.70 |
Pending
|
$126.33
+20.3%
|
| Apr 10, 2026 |
Abbvie Inc
ABBV
|
BUY |
$249.00
Est. +18%
|
$210.15 | $267.47 |
Target Met
|
$250.88
+19.4%
|
| Jan 23, 2026 |
Johnson & Johnson
JNJ
|
BUY |
$240.00
Est. +10%
|
$218.49 | $274.90 |
Target Met
|
$262.08
+20.0%
|
| Jan 16, 2026 |
ANI Pharmaceuticals Inc
ANIP
|
BUY |
$124.00
Est. +45%
|
$85.29 | $87.76 |
Pending
|
$74.77
-12.3%
|
| Jan 14, 2026 |
Travere Therapeutics Inc
TVTX
|
BUY |
$49.00
Est. +73%
|
$28.39 | $66.24 |
Target Met
|
$61.41
+116.3%
|
| Sep 08, 2025 |
ANI Pharmaceuticals Inc
ANIP
|
BUY |
$114.00
Est. +20%
|
$95.20 | $99.50 |
Pending
|
$74.77
-21.5%
|
| Jun 16, 2025 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$14.00
Est. +107%
|
$6.76 | $27.96 |
Target Met
|
$23.81
+252.2%
|
| Mar 24, 2025 |
Valneva SE - ADR
VALN
|
BUY |
$15.00
Est. +102%
|
$7.43 | $12.25 |
Miss
|
$5.65
-24.0%
|
| Feb 03, 2025 |
Johnson & Johnson
JNJ
|
BUY |
$166.00
Est. +9%
|
$151.87 | $231.19 |
Target Met
|
$262.08
+72.6%
|
| Sep 27, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$23.00
Est. +53%
|
$15.04 | $28.69 |
Target Met
|
$61.41
+308.3%
|
| Sep 23, 2024 |
Keros Therapeutics Inc
KROS
|
BUY |
$96.00
Est. +72%
|
$55.80 | $72.37 |
Miss
|
$10.66
-80.9%
|
| Sep 09, 2024 |
ExlService Holdings Inc
EXLS
|
SELL |
$25.00
Est. +31%
|
$36.18 | $35.52 (Low) |
Miss
|
$35.37
+2.2%
|
| Sep 09, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$25.00
Est. +296%
|
$6.31 | $25.29 |
Precision Hit (±3%)
|
$61.41
+873.2%
|
| Jul 30, 2024 |
Pfizer Inc.
PFE
|
BUY |
$36.00
Est. +17%
|
$30.72 | $31.54 |
Miss
|
$26.80
-12.8%
|
| Jul 09, 2024 |
Insmed Inc
INSM
|
BUY |
$95.00
Est. +36%
|
$70.05 | $106.83 |
Target Met
|
$126.33
+80.3%
|
| Jun 27, 2024 |
Savara Inc
SVRA
|
BUY |
$10.00
Est. +421%
|
$1.92 | $5.11 |
Miss
|
$5.27
+174.5%
|
| Apr 11, 2024 |
GSK Plc - ADR
GSK
|
SELL |
$36.00
Est. +12%
|
$40.69 | $31.72 (Low) |
Target Met
|
$50.45
-24.0%
|
| Apr 09, 2024 |
Alpine Immune Sciences Inc
ALPN
|
BUY |
$55.00
Est. +43%
|
$38.53 | $65.00 |
Target Met
|
$64.97
+68.6%
|
| May 09, 2023 |
Abbvie Inc
ABBV
|
BUY |
$171.00
Est. +16%
|
$147.01 | - | - |
$250.88
+70.7%
|